Midwest College of Oriental Medicine COVID-19 Preparedness Plan

Leave a Comment / College News, Corona Virus Updates / By

COVID-19 Preparedness  and Clinic Reopening Plan Update September 21, 2022 The College leadership delayed partial re-opening until March 2021 to give the administration, faculty, and students a chance to get the COVID-19 vaccination. The College continues to monitor the guidance of the CDC and the state and local health departments. Their recommendation and mandates as […]

Midwest College of Oriental Medicine COVID-19 Preparedness Plan Read More »

NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment

Leave a Comment / Long COVID / By

Today, July 31,2023, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months. Treatments will include drugs, biologics, medical devices and other therapies.

NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment Read More »

FDA, CDC push ahead with new COVID-19 boosters for kids without proper data

Leave a Comment / Vaccine Development / By

An opinion by Nicole Saphier, M.D. The Food and Drug Administration (FDA) has authorized the bivalent COVID-19 booster shots from both Pfizer-BioNTech and Moderna in kids as young as 5 years old. Approval from the Centers for Disease Control and Prevention (CDC) followed in lockstep, as they have for the last two years.  The new, updated bivalent booster

FDA, CDC push ahead with new COVID-19 boosters for kids without proper data Read More »

Scientists on alert as new Covid strain tears through ‘multiple countries’

Leave a Comment / Corona Virus Updates / By

A new Covid variant is ripping through “multiple countries”, with experts fearing it could be even more transmissible than the BA. 5 Omicron strain. Named BF. 7 – short for BA. 5.2.1.7 – the new variant is spreading faster than most other variants of interest that scientists are currently tracking in the US. While it

Scientists on alert as new Covid strain tears through ‘multiple countries’ Read More »

FDA expected to authorize new Covid boosters without data from tests on people

Leave a Comment / Vaccine Development / By

The lack of human data means officials likely won’t know how much better the new shots are — if at all — until the fall booster campaign is well underway. The updated Covid vaccine boosters, a reformulated version targeting the BA.5 omicron subvariant, could be available around Labor Day. They’ll be the first Covid shots distributed

FDA expected to authorize new Covid boosters without data from tests on people Read More »

BA.2.12.1, BA.4, and BA.5 escape antibodies elicited by Omicron infection

Leave a Comment / Uncategorized / By

SARS-CoV-2 Omicron sublineages BA.2.12.1, BA.4 and BA.5 exhibit higher transmissibility over BA.21. The new variants’ receptor binding and immune evasion capability require immediate investigation. Here, coupled with Spike structural comparisons, we show that BA.2.12.1 and BA.4/BA.5 exhibit comparable ACE2-binding affinities to BA.2. Importantly, BA.2.12.1 and BA.4/BA.5 display stronger neutralization evasion than BA.2 against the plasma

BA.2.12.1, BA.4, and BA.5 escape antibodies elicited by Omicron infection Read More »

Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States

Leave a Comment / Uncategorized / By

Summary – What is already known about this topic? SARS-CoV-2 infection is associated with worsening of diabetes symptoms, and persons with diabetes are at increased risk for severe COVID-19. SARS-CoV-2 infection might also induce newly diagnosed diabetes. What is added by this report? Persons aged <18 years with COVID-19 were more likely to receive a

Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States Read More »

New COVID-19 Vaccine Effectiveness Data Showcase Protection Gained by 3rd and 4th Doses

Leave a Comment / WHO and CDC Guidance and Information / By

A third and fourth COVID-19 vaccine dose offered substantial protection among adults with healthy immune systems who were eligible to receive them during Omicron variant evolution in early 2022, according to a new MMWR published today. The findings of this study, in conjunction with recently published data showing people infected with BA.2 may also have antibodies that can

New COVID-19 Vaccine Effectiveness Data Showcase Protection Gained by 3rd and 4th Doses Read More »

Subvariant May Be More Dangerous Than Omicron: Study

Leave a Comment / Omicron Variant / By

Abstract Soon after the emergence and global spread of a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron lineage, BA.1 (ref1, 2), another Omicron lineage, BA.2, has initiated outcompeting BA.1. Statistical analysis shows that the effective reproduction number of BA.2 is 1.4-fold higher than that of BA.1. Neutralisation experiments show that the vaccine-induced humoral immunity

Subvariant May Be More Dangerous Than Omicron: Study Read More »

Recurrent COVID-19 reinfection and re-emergence of a chronic infection reservoir?, a Brazilian study

Leave a Comment / Covid Re-infection / By

Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers Highlights We describe 33 patients with recurrent COVID19 and a positive PCR. Recurrence is associated with working as a healthcare professional, blood-group A, and low IgG response to infection. Evidence from differential virus sequencing between the first and second episode supports de

Recurrent COVID-19 reinfection and re-emergence of a chronic infection reservoir?, a Brazilian study Read More »

css.php
Scroll to Top